Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) EPS (Weighted Average and Diluted) (2022 - 2026)

Cannabis Bioscience International Holdings' EPS (Weighted Average and Diluted) history spans 5 years, with the latest figure at -$0.0 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 47.06% to -$0.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$0.0, a 97.14% decrease, with the full-year FY2025 number at -$0.0, up 16.67% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.0 in Q1 2026 for Cannabis Bioscience International Holdings, up from -$0.0 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for CBIH hit a ceiling of -$0.0 in Q3 2024 and a floor of -$0.0 in Q2 2025.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.0 across 5 years, with a median of -$0.0 in 2023.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 65.0% in 2024 and later crashed 368.0% in 2025.
  • Tracing CBIH's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.0 in 2022, then surged by 60.05% to -$0.0 in 2023, then grew by 20.0% to -$0.0 in 2024, then decreased by 25.0% to -$0.0 in 2025, then increased by 10.0% to -$0.0 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for CBIH at -$0.0 in Q1 2026, -$0.0 in Q4 2025, and -$0.0 in Q3 2025.